Skip to main content
Clinical Trials/NCT02243943
NCT02243943
Completed
Phase 4

Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit

Leiden University Medical Center1 site in 1 country100 target enrollmentSeptember 2014

Overview

Phase
Phase 4
Intervention
Sugammadex
Conditions
Postoperative Respiratory Condition
Sponsor
Leiden University Medical Center
Enrollment
100
Locations
1
Primary Endpoint
Mean Lowest Saturation
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Suboptimal reversal of neuromuscular blockage after surgery is possibly related to unfavorable postoperative respiratory conditions and elevated pain levels. Rapid and complete reversal of neuromuscular block was not possible untill sugammadex was discovered. The investigators hyposthesise that reversal with sugammadex leads to favorable postoperative respiratory conditions and less pain compared to reversal with neostigmine.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
April 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Leiden University Medical Center
Responsible Party
Principal Investigator
Principal Investigator

Albert Dahan

Prof. Dr. A. Dahan

Leiden University Medical Center

Eligibility Criteria

Inclusion Criteria

  • Age 18 years
  • - BMI \< 35
  • -ASA class I- III
  • -Patients scheduled for surgery requiring general anesthesia with the use of NMBA's
  • Patients with ability to give oral and written informed consent

Exclusion Criteria

  • Failure to meet the inclusion criteria
  • -Known or suspected neuromuscular disorders impairing neuromuscular function
  • -Allergies to muscle relaxants, anesthetics or narcotics
  • A (family) history of malignant hyperthermia
  • -Women who are or may be pregnant or are currently breast feeding
  • -Contraindications for the use of neostigmine
  • Intestinal obstruction,
  • COPD GOLD 4
  • -Abnormal heart rhythm (eg. bradycardia: \< 40/min);
  • -Surgery requiring neuraxial anesthesia / analgesia

Arms & Interventions

Sugammadex

Subjects in this arm will be reversed with sugammadex 2-4 mg/kg

Intervention: Sugammadex

neostigmine

subjects in this arm will be reversed with neostigmine 1.0-2.5 mg and atropine 0.5-1.0mg

Intervention: Neostigmine

Outcomes

Primary Outcomes

Mean Lowest Saturation

Time Frame: 45 minutes post surgery

Mean saturation is the mean value of the beat-to-beat Hb-oxygen saturation measured by finger pulse oximeter as measured in the first 45 min in the recovery room following surgery

Secondary Outcomes

  • Sedation(45 minutes post surgery)
  • Pain(45 minutes post surgery)

Study Sites (1)

Loading locations...

Similar Trials